ACT 066, SB505 SD1 HD2 CD1, 7/03/2017Posted on Jul 5, 2017 in 2017 Acts
RELATING TO HEALTH
Requires prescribing healthcare providers to adopt and maintain policies for informed consent to opioid therapy in circumstances that carry elevated risk of dependency. Establishes limits for concurrent opioid and benzodiazepine prescriptions. Clarifies Board of Nursing authority to enforce compliance with Uniform Controlled Substances Act. Repeals 6/30/2023.